CD28 and neoplasm: In particular, tumor‐infiltrating T cells are typically presented with classic immunosenescent characteristics, incorporating with impaired production of cytokines (e.g., GZMB) and phenotypic changes (e.g., downregulated expression of CD28 and upregulated expression of Tim‐3).